INDONESIA Trends and Developments Contributed by: Marshall Situmorang, Audria Putri, Fatya Alesi and Irfan Yusuf, Nusantara Legal Partnership
ness activities and also sets out a structured admin - istrative sanctions regime. In practical terms, this means that a clinic that is formally established but not yet fully aligned from an operational perspective may still face material regulatory exposure after launch. Accordingly, investors should be cautious about any business plan that assumes that compliance matters can simply be regularised after operations have com - menced. 2. Recent enforcement trends and compliance exposure Recent public reporting has also highlighted enforce - ment concerns regarding unlicensed or non-compliant aesthetic and beauty clinic activities, including cases involving operators who allegedly lacked the neces - sary qualifications or used products or equipment without required approvals. While such reports should not be read as representing the regulator’s position in every case, they reinforce the broader market real - ity that licensing and personnel compliance are now receiving closer public and regulatory attention. 3. Broader regulatory and operational considerations Another relevant development is that the current framework places greater practical emphasis not only on the clinic entity itself, but also on location, sup - porting arrangements, waste management, service readiness and personnel licensing. This is why private clinic investments, especially in specialist or premium healthcare models, should be assessed holistically. A commercially attractive clinic concept may still face regulatory difficulty if the site is unsuitable, the staffing model is incomplete, the service scope is overly ambi - tious for the proposed structure, or the supporting arrangements are not properly documented.
4. Continuing market opportunity and investment takeaway At the same time, the Indonesian market remains open to properly structured healthcare investments. The direction of the recent regulatory changes suggests that the government is not seeking to close the private healthcare sector, but rather to channel it through a more orderly, standards-based and digitally integrated framework. For investors, this means that the oppor - tunity in the private clinic sector remains real, but the success of the investment will depend increasingly on execution discipline, including proper structuring, cor - rect licensing, staffing readiness, site suitability and post-closing compliance management. In that sense, private clinic investment in Indonesia should now be viewed as a regulated platform play rather than a simple company establishment exercise. Whether the investment is pursued through a green - field clinic or through M&A, investors should approach the project with an integrated review of the corpo - rate, licensing, operational and healthcare compliance aspects from the outset.
617 CHAMBERS.COM
Powered by FlippingBook